nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobetasol propionate—Application site burn—Fluorouracil—urinary bladder cancer	0.0237	0.0449	CcSEcCtD
Clobetasol propionate—Telangiectasia—Fluorouracil—urinary bladder cancer	0.0211	0.0399	CcSEcCtD
Clobetasol propionate—CYP1A2—urine—urinary bladder cancer	0.0192	0.182	CbGeAlD
Clobetasol propionate—NR3C1—urine—urinary bladder cancer	0.0184	0.175	CbGeAlD
Clobetasol propionate—Stinging—Mitomycin—urinary bladder cancer	0.0147	0.0279	CcSEcCtD
Clobetasol propionate—Allergic contact dermatitis—Fluorouracil—urinary bladder cancer	0.0142	0.0269	CcSEcCtD
Clobetasol propionate—Leukoderma—Thiotepa—urinary bladder cancer	0.0141	0.0268	CcSEcCtD
Clobetasol propionate—Application site pain—Fluorouracil—urinary bladder cancer	0.0113	0.0214	CcSEcCtD
Clobetasol propionate—Telangiectasia—Methotrexate—urinary bladder cancer	0.011	0.0208	CcSEcCtD
Clobetasol propionate—Application site reaction—Fluorouracil—urinary bladder cancer	0.0106	0.0201	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Thiotepa—urinary bladder cancer	0.0101	0.0191	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Valrubicin—urinary bladder cancer	0.00981	0.0186	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Valrubicin—urinary bladder cancer	0.00857	0.0162	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Fluorouracil—urinary bladder cancer	0.00835	0.0158	CcSEcCtD
Clobetasol propionate—Secondary infection—Epirubicin—urinary bladder cancer	0.00822	0.0156	CcSEcCtD
Clobetasol propionate—Eruption—Gemcitabine—urinary bladder cancer	0.00821	0.0156	CcSEcCtD
Clobetasol propionate—Secondary infection—Doxorubicin—urinary bladder cancer	0.00761	0.0144	CcSEcCtD
Clobetasol propionate—NR3C1—prostate gland—urinary bladder cancer	0.0066	0.0627	CbGeAlD
Clobetasol propionate—Tingling sensation—Fluorouracil—urinary bladder cancer	0.00618	0.0117	CcSEcCtD
Clobetasol propionate—Stinging—Fluorouracil—urinary bladder cancer	0.00613	0.0116	CcSEcCtD
Clobetasol propionate—Leukoderma—Methotrexate—urinary bladder cancer	0.00608	0.0115	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Thiotepa—urinary bladder cancer	0.00593	0.0112	CcSEcCtD
Clobetasol propionate—Eye irritation—Fluorouracil—urinary bladder cancer	0.00581	0.011	CcSEcCtD
Clobetasol propionate—Tenderness—Gemcitabine—urinary bladder cancer	0.00579	0.011	CcSEcCtD
Clobetasol propionate—Tenderness—Fluorouracil—urinary bladder cancer	0.00569	0.0108	CcSEcCtD
Clobetasol propionate—Infection—Carboplatin—urinary bladder cancer	0.00569	0.0108	CcSEcCtD
Clobetasol propionate—Leukoderma—Epirubicin—urinary bladder cancer	0.00569	0.0108	CcSEcCtD
Clobetasol propionate—NR3C1—seminal vesicle—urinary bladder cancer	0.00559	0.053	CbGeAlD
Clobetasol propionate—Tenderness—Cisplatin—urinary bladder cancer	0.00539	0.0102	CcSEcCtD
Clobetasol propionate—Tingling sensation—Etoposide—urinary bladder cancer	0.00536	0.0102	CcSEcCtD
Clobetasol propionate—Alopecia—Mitomycin—urinary bladder cancer	0.0053	0.01	CcSEcCtD
Clobetasol propionate—Leukoderma—Doxorubicin—urinary bladder cancer	0.00526	0.00997	CcSEcCtD
Clobetasol propionate—Erythema—Mitomycin—urinary bladder cancer	0.00522	0.00989	CcSEcCtD
Clobetasol propionate—CYP1A1—epithelium—urinary bladder cancer	0.005	0.0475	CbGeAlD
Clobetasol propionate—Dermatitis contact—Fluorouracil—urinary bladder cancer	0.00491	0.0093	CcSEcCtD
Clobetasol propionate—Pain—Carboplatin—urinary bladder cancer	0.0049	0.00928	CcSEcCtD
Clobetasol propionate—NR3C1—epithelium—urinary bladder cancer	0.00485	0.0461	CbGeAlD
Clobetasol propionate—CYP1A2—renal system—urinary bladder cancer	0.0047	0.0446	CbGeAlD
Clobetasol propionate—NR3C1—smooth muscle tissue—urinary bladder cancer	0.00468	0.0444	CbGeAlD
Clobetasol propionate—CYP1A1—renal system—urinary bladder cancer	0.00464	0.044	CbGeAlD
Clobetasol propionate—CYP1A1—urethra—urinary bladder cancer	0.00456	0.0432	CbGeAlD
Clobetasol propionate—NR3C1—renal system—urinary bladder cancer	0.0045	0.0427	CbGeAlD
Clobetasol propionate—NR3C1—urethra—urinary bladder cancer	0.00442	0.042	CbGeAlD
Clobetasol propionate—Pruritus—Valrubicin—urinary bladder cancer	0.00437	0.00829	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Methotrexate—urinary bladder cancer	0.00434	0.00823	CcSEcCtD
Clobetasol propionate—Eruption—Methotrexate—urinary bladder cancer	0.0042	0.00796	CcSEcCtD
Clobetasol propionate—Psoriasis—Methotrexate—urinary bladder cancer	0.00411	0.00779	CcSEcCtD
Clobetasol propionate—Folliculitis—Methotrexate—urinary bladder cancer	0.00411	0.00779	CcSEcCtD
Clobetasol propionate—Skin hyperpigmentation—Epirubicin—urinary bladder cancer	0.00406	0.0077	CcSEcCtD
Clobetasol propionate—Eruption—Epirubicin—urinary bladder cancer	0.00393	0.00745	CcSEcCtD
Clobetasol propionate—Rash—Valrubicin—urinary bladder cancer	0.0039	0.00739	CcSEcCtD
Clobetasol propionate—Dermatitis—Valrubicin—urinary bladder cancer	0.00389	0.00738	CcSEcCtD
Clobetasol propionate—Headache—Valrubicin—urinary bladder cancer	0.00387	0.00734	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.00386	0.0106	CbGpPWpGaD
Clobetasol propionate—Folliculitis—Epirubicin—urinary bladder cancer	0.00385	0.00729	CcSEcCtD
Clobetasol propionate—Psoriasis—Epirubicin—urinary bladder cancer	0.00385	0.00729	CcSEcCtD
Clobetasol propionate—CYP1A1—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00379	0.0104	CbGpPWpGaD
Clobetasol propionate—Skin hyperpigmentation—Doxorubicin—urinary bladder cancer	0.00376	0.00713	CcSEcCtD
Clobetasol propionate—CYP1A1—female reproductive system—urinary bladder cancer	0.00372	0.0353	CbGeAlD
Clobetasol propionate—Pain—Mitomycin—urinary bladder cancer	0.00364	0.0069	CcSEcCtD
Clobetasol propionate—Eruption—Doxorubicin—urinary bladder cancer	0.00364	0.00689	CcSEcCtD
Clobetasol propionate—NR3C1—female reproductive system—urinary bladder cancer	0.00361	0.0342	CbGeAlD
Clobetasol propionate—CYP1A1—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00357	0.00976	CbGpPWpGaD
Clobetasol propionate—Folliculitis—Doxorubicin—urinary bladder cancer	0.00356	0.00674	CcSEcCtD
Clobetasol propionate—Psoriasis—Doxorubicin—urinary bladder cancer	0.00356	0.00674	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—urinary bladder cancer	0.00344	0.0094	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Thiotepa—urinary bladder cancer	0.0034	0.00644	CcSEcCtD
Clobetasol propionate—CYP1A1—vagina—urinary bladder cancer	0.00336	0.0319	CbGeAlD
Clobetasol propionate—Dry skin—Fluorouracil—urinary bladder cancer	0.0033	0.00626	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—NQO1—urinary bladder cancer	0.00329	0.00899	CbGpPWpGaD
Clobetasol propionate—NR3C1—vagina—urinary bladder cancer	0.00326	0.0309	CbGeAlD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—CYP4B1—urinary bladder cancer	0.00325	0.00888	CbGpPWpGaD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—ESR2—urinary bladder cancer	0.00317	0.00867	CbGpPWpGaD
Clobetasol propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—urinary bladder cancer	0.00317	0.00866	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen metabolism—NQO1—urinary bladder cancer	0.00315	0.00862	CbGpPWpGaD
Clobetasol propionate—Rash pustular—Epirubicin—urinary bladder cancer	0.00303	0.00574	CcSEcCtD
Clobetasol propionate—Stinging—Epirubicin—urinary bladder cancer	0.00298	0.00565	CcSEcCtD
Clobetasol propionate—Glycosuria—Epirubicin—urinary bladder cancer	0.00298	0.00565	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Thiotepa—urinary bladder cancer	0.00296	0.00561	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.0029	0.00792	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Gemcitabine—urinary bladder cancer	0.00286	0.00542	CcSEcCtD
Clobetasol propionate—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.00281	0.00768	CbGpPWpGaD
Clobetasol propionate—Rash pustular—Doxorubicin—urinary bladder cancer	0.0028	0.00531	CcSEcCtD
Clobetasol propionate—CYP1A2—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.00277	0.00757	CbGpPWpGaD
Clobetasol propionate—Glycosuria—Doxorubicin—urinary bladder cancer	0.00276	0.00523	CcSEcCtD
Clobetasol propionate—Stinging—Doxorubicin—urinary bladder cancer	0.00276	0.00523	CcSEcCtD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00271	0.00741	CbGpPWpGaD
Clobetasol propionate—Rash—Mitomycin—urinary bladder cancer	0.00269	0.00509	CcSEcCtD
Clobetasol propionate—Dermatitis—Mitomycin—urinary bladder cancer	0.00268	0.00508	CcSEcCtD
Clobetasol propionate—Headache—Mitomycin—urinary bladder cancer	0.00267	0.00506	CcSEcCtD
Clobetasol propionate—Alopecia—Thiotepa—urinary bladder cancer	0.00266	0.00505	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTZ1—urinary bladder cancer	0.00265	0.00724	CbGpPWpGaD
Clobetasol propionate—Erythema—Thiotepa—urinary bladder cancer	0.00262	0.00497	CcSEcCtD
Clobetasol propionate—CYP1A1—Oxidative Stress—SOD2—urinary bladder cancer	0.00253	0.00691	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTO2—urinary bladder cancer	0.00251	0.00686	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—NAT1—urinary bladder cancer	0.00251	0.00686	CbGpPWpGaD
Clobetasol propionate—Oedema peripheral—Gemcitabine—urinary bladder cancer	0.0025	0.00473	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.00249	0.00472	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00248	0.0047	CcSEcCtD
Clobetasol propionate—CYP1A2—Estrogen Receptor Pathway—ESR1—urinary bladder cancer	0.00246	0.00673	CbGpPWpGaD
Clobetasol propionate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—urinary bladder cancer	0.00244	0.00666	CbGpPWpGaD
Clobetasol propionate—NR3C1—Nuclear Receptors—ESR1—urinary bladder cancer	0.00244	0.00666	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTZ1—urinary bladder cancer	0.00243	0.00664	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Estrogen metabolism—GSTM1—urinary bladder cancer	0.00242	0.00661	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Oxidative Stress—GPX1—urinary bladder cancer	0.00241	0.0066	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.0024	0.00655	CbGpPWpGaD
Clobetasol propionate—Dermatitis contact—Epirubicin—urinary bladder cancer	0.00239	0.00453	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.00233	0.00638	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.00233	0.00638	CbGpPWpGaD
Clobetasol propionate—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.00232	0.0044	CcSEcCtD
Clobetasol propionate—NR3C1—Circadian Clock—NCOR1—urinary bladder cancer	0.00231	0.00631	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTO2—urinary bladder cancer	0.0023	0.00629	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—NAT1—urinary bladder cancer	0.0023	0.00629	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—UGT2B7—urinary bladder cancer	0.0023	0.00627	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.00228	0.00622	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00227	0.00621	CbGpPWpGaD
Clobetasol propionate—Alopecia—Gemcitabine—urinary bladder cancer	0.00224	0.00425	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptors—PPARG—urinary bladder cancer	0.00222	0.00607	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00222	0.0042	CcSEcCtD
Clobetasol propionate—Dermatitis contact—Doxorubicin—urinary bladder cancer	0.00221	0.00419	CcSEcCtD
Clobetasol propionate—Erythema—Gemcitabine—urinary bladder cancer	0.00221	0.00418	CcSEcCtD
Clobetasol propionate—Alopecia—Fluorouracil—urinary bladder cancer	0.0022	0.00418	CcSEcCtD
Clobetasol propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—urinary bladder cancer	0.00218	0.00596	CbGpPWpGaD
Clobetasol propionate—CYP1A1—lymph node—urinary bladder cancer	0.00217	0.0206	CbGeAlD
Clobetasol propionate—Erythema—Fluorouracil—urinary bladder cancer	0.00217	0.00411	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00215	0.00408	CcSEcCtD
Clobetasol propionate—Infection—Thiotepa—urinary bladder cancer	0.00213	0.00403	CcSEcCtD
Clobetasol propionate—NR3C1—lymph node—urinary bladder cancer	0.00211	0.02	CbGeAlD
Clobetasol propionate—CYP1A1—Biological oxidations—UGT2B7—urinary bladder cancer	0.00211	0.00576	CbGpPWpGaD
Clobetasol propionate—Alopecia—Cisplatin—urinary bladder cancer	0.00209	0.00396	CcSEcCtD
Clobetasol propionate—Skin disorder—Thiotepa—urinary bladder cancer	0.00208	0.00394	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00208	0.00568	CbGpPWpGaD
Clobetasol propionate—Erythema—Cisplatin—urinary bladder cancer	0.00206	0.0039	CcSEcCtD
Clobetasol propionate—Vascular purpura—Epirubicin—urinary bladder cancer	0.00196	0.00372	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—ESR1—urinary bladder cancer	0.00192	0.00526	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Thiotepa—urinary bladder cancer	0.00192	0.00364	CcSEcCtD
Clobetasol propionate—Alopecia—Etoposide—urinary bladder cancer	0.00191	0.00363	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—CYP4B1—urinary bladder cancer	0.0019	0.00518	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00187	0.00511	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00187	0.00354	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—urinary bladder cancer	0.00185	0.00505	CbGpPWpGaD
Clobetasol propionate—Pain—Thiotepa—urinary bladder cancer	0.00183	0.00347	CcSEcCtD
Clobetasol propionate—NR3C1—Transcription factor regulation in adipogenesis—TNF—urinary bladder cancer	0.00183	0.00499	CbGpPWpGaD
Clobetasol propionate—Purpura—Epirubicin—urinary bladder cancer	0.00182	0.00345	CcSEcCtD
Clobetasol propionate—Vascular purpura—Doxorubicin—urinary bladder cancer	0.00181	0.00344	CcSEcCtD
Clobetasol propionate—Infection—Gemcitabine—urinary bladder cancer	0.00179	0.00339	CcSEcCtD
Clobetasol propionate—Infection—Fluorouracil—urinary bladder cancer	0.00176	0.00333	CcSEcCtD
Clobetasol propionate—NR3C1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00176	0.0048	CbGpPWpGaD
Clobetasol propionate—Pain in extremity—Epirubicin—urinary bladder cancer	0.00175	0.00332	CcSEcCtD
Clobetasol propionate—Skin disorder—Gemcitabine—urinary bladder cancer	0.00175	0.00332	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00174	0.0033	CcSEcCtD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—HPGDS—urinary bladder cancer	0.00173	0.00472	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00169	0.00463	CbGpPWpGaD
Clobetasol propionate—Purpura—Doxorubicin—urinary bladder cancer	0.00168	0.00319	CcSEcCtD
Clobetasol propionate—Infection—Cisplatin—urinary bladder cancer	0.00167	0.00316	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—CREBBP—urinary bladder cancer	0.00164	0.00447	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Cisplatin—urinary bladder cancer	0.00163	0.00309	CcSEcCtD
Clobetasol propionate—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00162	0.00308	CcSEcCtD
Clobetasol propionate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00162	0.00307	CcSEcCtD
Clobetasol propionate—Dry skin—Epirubicin—urinary bladder cancer	0.00161	0.00305	CcSEcCtD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.0016	0.00438	CbGpPWpGaD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00159	0.00302	CcSEcCtD
Clobetasol propionate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00159	0.00301	CcSEcCtD
Clobetasol propionate—NR3C1—Circadian Clock—CREBBP—urinary bladder cancer	0.00159	0.00434	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.00159	0.00434	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00158	0.00299	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTZ1—urinary bladder cancer	0.00155	0.00423	CbGpPWpGaD
Clobetasol propionate—Pain—Gemcitabine—urinary bladder cancer	0.00154	0.00292	CcSEcCtD
Clobetasol propionate—Infection—Etoposide—urinary bladder cancer	0.00153	0.0029	CcSEcCtD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.00153	0.00418	CbGpPWpGaD
Clobetasol propionate—Pruritus—Thiotepa—urinary bladder cancer	0.00152	0.00287	CcSEcCtD
Clobetasol propionate—Pain—Fluorouracil—urinary bladder cancer	0.00151	0.00287	CcSEcCtD
Clobetasol propionate—Paraesthesia—Cisplatin—urinary bladder cancer	0.00151	0.00286	CcSEcCtD
Clobetasol propionate—Skin disorder—Etoposide—urinary bladder cancer	0.00149	0.00283	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—ESR1—urinary bladder cancer	0.00149	0.00408	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—NQO1—urinary bladder cancer	0.00149	0.00407	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NQO1—urinary bladder cancer	0.00149	0.00407	CbGpPWpGaD
Clobetasol propionate—Dry skin—Doxorubicin—urinary bladder cancer	0.00149	0.00282	CcSEcCtD
Clobetasol propionate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—urinary bladder cancer	0.00148	0.00406	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—NAT1—urinary bladder cancer	0.00147	0.00401	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTO2—urinary bladder cancer	0.00147	0.00401	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.00145	0.00396	CbGpPWpGaD
Clobetasol propionate—Pain—Cisplatin—urinary bladder cancer	0.00144	0.00272	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.00141	0.00384	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Etoposide—urinary bladder cancer	0.00138	0.00262	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—NAT2—urinary bladder cancer	0.00138	0.00376	CbGpPWpGaD
Clobetasol propionate—Hyperglycaemia—Epirubicin—urinary bladder cancer	0.00137	0.00259	CcSEcCtD
Clobetasol propionate—Rash—Thiotepa—urinary bladder cancer	0.00135	0.00256	CcSEcCtD
Clobetasol propionate—Dermatitis—Thiotepa—urinary bladder cancer	0.00135	0.00256	CcSEcCtD
Clobetasol propionate—CYP1A2—Biological oxidations—UGT2B7—urinary bladder cancer	0.00134	0.00367	CbGpPWpGaD
Clobetasol propionate—Headache—Thiotepa—urinary bladder cancer	0.00134	0.00254	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.00133	0.00365	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—urinary bladder cancer	0.00133	0.00363	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00132	0.00362	CbGpPWpGaD
Clobetasol propionate—Pain—Etoposide—urinary bladder cancer	0.00132	0.00249	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00131	0.00247	CcSEcCtD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.0013	0.00355	CbGpPWpGaD
Clobetasol propionate—Pruritus—Gemcitabine—urinary bladder cancer	0.00127	0.00242	CcSEcCtD
Clobetasol propionate—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.00127	0.0024	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—NAT2—urinary bladder cancer	0.00126	0.00345	CbGpPWpGaD
Clobetasol propionate—Pruritus—Fluorouracil—urinary bladder cancer	0.00125	0.00237	CcSEcCtD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—NAT2—urinary bladder cancer	0.00124	0.0034	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00124	0.00234	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.00123	0.00336	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—CYP4B1—urinary bladder cancer	0.00121	0.00331	CbGpPWpGaD
Clobetasol propionate—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00121	0.00229	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Epirubicin—urinary bladder cancer	0.0012	0.00227	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00119	0.00226	CcSEcCtD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.00119	0.00326	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.00116	0.00318	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—NCOR1—urinary bladder cancer	0.00116	0.00317	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—urinary bladder cancer	0.00115	0.00315	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.00115	0.00313	CbGpPWpGaD
Clobetasol propionate—Alopecia—Methotrexate—urinary bladder cancer	0.00115	0.00217	CcSEcCtD
Clobetasol propionate—Rash—Gemcitabine—urinary bladder cancer	0.00114	0.00215	CcSEcCtD
Clobetasol propionate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00113	0.00215	CcSEcCtD
Clobetasol propionate—Hypersensitivity—Etoposide—urinary bladder cancer	0.00113	0.00215	CcSEcCtD
Clobetasol propionate—Erythema—Methotrexate—urinary bladder cancer	0.00113	0.00214	CcSEcCtD
Clobetasol propionate—Headache—Gemcitabine—urinary bladder cancer	0.00113	0.00214	CcSEcCtD
Clobetasol propionate—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00112	0.00212	CcSEcCtD
Clobetasol propionate—Rash—Fluorouracil—urinary bladder cancer	0.00112	0.00212	CcSEcCtD
Clobetasol propionate—Dermatitis—Fluorouracil—urinary bladder cancer	0.00112	0.00211	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—EP300—urinary bladder cancer	0.00111	0.00305	CbGpPWpGaD
Clobetasol propionate—Headache—Fluorouracil—urinary bladder cancer	0.00111	0.0021	CcSEcCtD
Clobetasol propionate—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.00111	0.0021	CcSEcCtD
Clobetasol propionate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.0011	0.00209	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—HPGDS—urinary bladder cancer	0.0011	0.00301	CbGpPWpGaD
Clobetasol propionate—Pruritus—Etoposide—urinary bladder cancer	0.00109	0.00206	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of Androgen receptor activity—SRC—urinary bladder cancer	0.00108	0.00296	CbGpPWpGaD
Clobetasol propionate—NR3C1—Circadian Clock—EP300—urinary bladder cancer	0.00108	0.00296	CbGpPWpGaD
Clobetasol propionate—Alopecia—Epirubicin—urinary bladder cancer	0.00107	0.00203	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTT1—urinary bladder cancer	0.00107	0.00291	CbGpPWpGaD
Clobetasol propionate—Rash—Cisplatin—urinary bladder cancer	0.00106	0.00201	CcSEcCtD
Clobetasol propionate—Dermatitis—Cisplatin—urinary bladder cancer	0.00106	0.002	CcSEcCtD
Clobetasol propionate—Erythema—Epirubicin—urinary bladder cancer	0.00106	0.002	CcSEcCtD
Clobetasol propionate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.00104	0.00285	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.00104	0.00284	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—FAS—urinary bladder cancer	0.00104	0.00284	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.00102	0.00279	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.00101	0.00276	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—HPGDS—urinary bladder cancer	0.00101	0.00276	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000994	0.00272	CbGpPWpGaD
Clobetasol propionate—Alopecia—Doxorubicin—urinary bladder cancer	0.000992	0.00188	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTT1—urinary bladder cancer	0.000978	0.00267	CbGpPWpGaD
Clobetasol propionate—Erythema—Doxorubicin—urinary bladder cancer	0.000978	0.00185	CcSEcCtD
Clobetasol propionate—Rash—Etoposide—urinary bladder cancer	0.00097	0.00184	CcSEcCtD
Clobetasol propionate—Dermatitis—Etoposide—urinary bladder cancer	0.000969	0.00184	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000969	0.00265	CbGpPWpGaD
Clobetasol propionate—Headache—Etoposide—urinary bladder cancer	0.000964	0.00183	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000955	0.00181	CcSEcCtD
Clobetasol propionate—CYP1A1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000944	0.00258	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.00094	0.00257	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000935	0.00256	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000935	0.00256	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—urinary bladder cancer	0.000916	0.0025	CbGpPWpGaD
Clobetasol propionate—Infection—Methotrexate—urinary bladder cancer	0.000915	0.00173	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—urinary bladder cancer	0.000896	0.00245	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Methotrexate—urinary bladder cancer	0.000895	0.0017	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000893	0.00169	CcSEcCtD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000892	0.00244	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—NCOR1—urinary bladder cancer	0.000891	0.00244	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000882	0.00241	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—IL2—urinary bladder cancer	0.000876	0.00239	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—NCOR1—urinary bladder cancer	0.000872	0.00238	CbGpPWpGaD
Clobetasol propionate—Infection—Epirubicin—urinary bladder cancer	0.000857	0.00162	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000839	0.00229	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000839	0.00229	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Epirubicin—urinary bladder cancer	0.000838	0.00159	CcSEcCtD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000834	0.00228	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—PPARG—urinary bladder cancer	0.000831	0.00227	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Methotrexate—urinary bladder cancer	0.000827	0.00157	CcSEcCtD
Clobetasol propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000827	0.00157	CcSEcCtD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—urinary bladder cancer	0.000826	0.00226	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000816	0.00223	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000816	0.00223	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—NAT2—urinary bladder cancer	0.000804	0.0022	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—RB1—urinary bladder cancer	0.000795	0.00217	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000793	0.00217	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000793	0.00217	CbGpPWpGaD
Clobetasol propionate—Infection—Doxorubicin—urinary bladder cancer	0.000793	0.0015	CcSEcCtD
Clobetasol propionate—Pain—Methotrexate—urinary bladder cancer	0.000788	0.00149	CcSEcCtD
Clobetasol propionate—NR3C1—Adipogenesis—IGF1—urinary bladder cancer	0.000788	0.00215	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—EP300—urinary bladder cancer	0.000786	0.00215	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000783	0.00214	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000777	0.00212	CbGpPWpGaD
Clobetasol propionate—Skin disorder—Doxorubicin—urinary bladder cancer	0.000775	0.00147	CcSEcCtD
Clobetasol propionate—Paraesthesia—Epirubicin—urinary bladder cancer	0.000774	0.00147	CcSEcCtD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTP1—urinary bladder cancer	0.000739	0.00202	CbGpPWpGaD
Clobetasol propionate—Pain—Epirubicin—urinary bladder cancer	0.000737	0.0014	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000731	0.002	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000728	0.00199	CbGpPWpGaD
Clobetasol propionate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000716	0.00136	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000715	0.00196	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000715	0.00196	CbGpPWpGaD
Clobetasol propionate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.000691	0.00189	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.00069	0.00189	CbGpPWpGaD
Clobetasol propionate—Pain—Doxorubicin—urinary bladder cancer	0.000682	0.00129	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000681	0.00186	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000681	0.00186	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Phase II conjugation—GSTM1—urinary bladder cancer	0.000679	0.00186	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000679	0.00129	CcSEcCtD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTP1—urinary bladder cancer	0.000678	0.00185	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000676	0.00185	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000669	0.00183	CbGpPWpGaD
Clobetasol propionate—Pruritus—Methotrexate—urinary bladder cancer	0.000652	0.00124	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000643	0.00176	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—HPGDS—urinary bladder cancer	0.000643	0.00176	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—PPARG—urinary bladder cancer	0.000639	0.00175	CbGpPWpGaD
Clobetasol propionate—NR3C1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000638	0.00174	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000635	0.0012	CcSEcCtD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—urinary bladder cancer	0.000625	0.00171	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTT1—urinary bladder cancer	0.000624	0.00171	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Biological oxidations—GSTM1—urinary bladder cancer	0.000623	0.0017	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000615	0.00168	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—CREBBP—urinary bladder cancer	0.000613	0.00168	CbGpPWpGaD
Clobetasol propionate—Pruritus—Epirubicin—urinary bladder cancer	0.00061	0.00116	CcSEcCtD
Clobetasol propionate—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000602	0.00165	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—urinary bladder cancer	0.000601	0.00164	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CREBBP—urinary bladder cancer	0.0006	0.00164	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000596	0.00163	CbGpPWpGaD
Clobetasol propionate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000588	0.00111	CcSEcCtD
Clobetasol propionate—Rash—Methotrexate—urinary bladder cancer	0.000581	0.0011	CcSEcCtD
Clobetasol propionate—Dermatitis—Methotrexate—urinary bladder cancer	0.00058	0.0011	CcSEcCtD
Clobetasol propionate—Headache—Methotrexate—urinary bladder cancer	0.000577	0.00109	CcSEcCtD
Clobetasol propionate—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000574	0.00157	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—CDKN1A—urinary bladder cancer	0.000571	0.00156	CbGpPWpGaD
Clobetasol propionate—Pruritus—Doxorubicin—urinary bladder cancer	0.000565	0.00107	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000562	0.00154	CbGpPWpGaD
Clobetasol propionate—NR3C1—Glucocorticoid receptor regulatory network—TP53—urinary bladder cancer	0.000562	0.00154	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000548	0.0015	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000548	0.0015	CbGpPWpGaD
Clobetasol propionate—Fluoxymesterone—ESR1—urinary bladder cancer	0.000544	0.478	CrCbGaD
Clobetasol propionate—Rash—Epirubicin—urinary bladder cancer	0.000544	0.00103	CcSEcCtD
Clobetasol propionate—Dermatitis—Epirubicin—urinary bladder cancer	0.000543	0.00103	CcSEcCtD
Clobetasol propionate—Headache—Epirubicin—urinary bladder cancer	0.00054	0.00102	CcSEcCtD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000535	0.00146	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000535	0.00146	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.00052	0.00142	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.00052	0.00142	CbGpPWpGaD
Clobetasol propionate—Rash—Doxorubicin—urinary bladder cancer	0.000503	0.000953	CcSEcCtD
Clobetasol propionate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000503	0.000953	CcSEcCtD
Clobetasol propionate—Headache—Doxorubicin—urinary bladder cancer	0.0005	0.000947	CcSEcCtD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	0.00047	0.00128	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000466	0.00127	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000464	0.00127	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000456	0.00125	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000456	0.00125	CbGpPWpGaD
Clobetasol propionate—NR3C1—Adipogenesis—TNF—urinary bladder cancer	0.000441	0.00121	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000434	0.00119	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000434	0.00119	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000432	0.00118	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000431	0.00118	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—urinary bladder cancer	0.000431	0.00118	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000426	0.00117	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000423	0.00116	CbGpPWpGaD
Clobetasol propionate—CYP1A1—PPARA activates gene expression—EP300—urinary bladder cancer	0.000418	0.00114	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTZ1—urinary bladder cancer	0.000415	0.00114	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—urinary bladder cancer	0.000414	0.00113	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—urinary bladder cancer	0.000409	0.00112	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000397	0.00109	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTO2—urinary bladder cancer	0.000394	0.00108	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NAT1—urinary bladder cancer	0.000394	0.00108	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000392	0.00107	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000387	0.00106	CbGpPWpGaD
Clobetasol propionate—NR3C1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.000381	0.00104	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000366	0.001	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—UGT2B7—urinary bladder cancer	0.00036	0.000985	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—ESR1—urinary bladder cancer	0.000332	0.000909	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CYP4B1—urinary bladder cancer	0.000324	0.000886	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—SLC19A1—urinary bladder cancer	0.000306	0.000837	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—PPARG—urinary bladder cancer	0.000303	0.000829	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—SMC1A—urinary bladder cancer	0.000303	0.000828	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PRSS3—urinary bladder cancer	0.000298	0.000816	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	0.000291	0.000796	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—urinary bladder cancer	0.000282	0.00077	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	0.000265	0.000724	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ESR2—urinary bladder cancer	0.000264	0.000721	CbGpPWpGaD
Clobetasol propionate—Triamcinolone—PTGS2—urinary bladder cancer	0.000259	0.227	CrCbGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	0.000251	0.000686	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NAT1—urinary bladder cancer	0.000251	0.000686	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000247	0.000675	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000239	0.000654	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—TYMP—urinary bladder cancer	0.000239	0.000652	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	0.00023	0.000628	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000229	0.000626	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NAT2—urinary bladder cancer	0.000216	0.00059	CbGpPWpGaD
Clobetasol propionate—Betamethasone—PTGS2—urinary bladder cancer	0.000212	0.186	CrCbGaD
Clobetasol propionate—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	0.000207	0.000565	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—NCOR1—urinary bladder cancer	0.000204	0.000557	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	0.000195	0.000534	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ERCC2—urinary bladder cancer	0.000192	0.000524	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	0.00019	0.00052	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—RRM2—urinary bladder cancer	0.000186	0.000509	CbGpPWpGaD
Clobetasol propionate—NR3C1—Generic Transcription Pathway—MYC—urinary bladder cancer	0.000173	0.000473	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ENO2—urinary bladder cancer	0.000172	0.000472	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—HPGDS—urinary bladder cancer	0.000172	0.000472	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000171	0.000469	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTT1—urinary bladder cancer	0.000167	0.000457	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000165	0.00045	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—ESR1—urinary bladder cancer	0.00016	0.000438	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000153	0.000417	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—TYMP—urinary bladder cancer	0.000152	0.000416	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000146	0.000399	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—PPARG—urinary bladder cancer	0.000146	0.000399	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—CREBBP—urinary bladder cancer	0.00014	0.000383	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NQO1—urinary bladder cancer	0.000139	0.00038	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NAT2—urinary bladder cancer	0.000138	0.000376	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000135	0.000369	CbGpPWpGaD
Clobetasol propionate—Dexamethasone—PTGS2—urinary bladder cancer	0.000123	0.108	CrCbGaD
Clobetasol propionate—CYP1A2—Metabolism—RRM2—urinary bladder cancer	0.000119	0.000325	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000118	0.000322	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	0.000116	0.000317	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000112	0.000307	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	0.00011	0.000301	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ENO2—urinary bladder cancer	0.00011	0.000301	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000109	0.000299	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—TYMS—urinary bladder cancer	0.000108	0.000295	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	0.000107	0.000292	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	0.000107	0.000291	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	0.000107	0.000291	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000105	0.000287	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—GPX1—urinary bladder cancer	0.000102	0.000279	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	0.0001	0.000274	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	9.42e-05	0.000257	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NQO1—urinary bladder cancer	8.86e-05	0.000242	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.6e-05	0.000235	CbGpPWpGaD
Clobetasol propionate—NR3C1—Gene Expression—MYC—urinary bladder cancer	8.32e-05	0.000228	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PPARG—urinary bladder cancer	7.64e-05	0.000209	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.5e-05	0.000205	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	7.39e-05	0.000202	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	7.34e-05	0.000201	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.15e-05	0.000196	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—TYMS—urinary bladder cancer	6.87e-05	0.000188	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	6.79e-05	0.000186	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	6.79e-05	0.000186	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—GPX1—urinary bladder cancer	6.51e-05	0.000178	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	6.39e-05	0.000175	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	6.01e-05	0.000164	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	6e-05	0.000164	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—PTEN—urinary bladder cancer	5.24e-05	0.000143	CbGpPWpGaD
Clobetasol propionate—CYP1A1—Metabolism—EP300—urinary bladder cancer	5e-05	0.000137	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PPARG—urinary bladder cancer	4.87e-05	0.000133	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	4.68e-05	0.000128	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	3.83e-05	0.000105	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.34e-05	9.13e-05	CbGpPWpGaD
Clobetasol propionate—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.19e-05	8.71e-05	CbGpPWpGaD
